Economic burden and co-morbidities of atrial fibrillation in a privately insured population

By Wu Eric Q.   Birnbaum Howard G.   Mareva Milena   Tuttle Edward   Castor Adam R.   Jackman Warren   Ruskin Jeremy  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1693-1699

Informa Healthcare

Access to resources Recommend Favorite

Insomnia-related comorbidities and economic costs among a commercially insured population in the United States

By Pollack Michael   Seal Brian   Joish Vijay N.   Cziraky Mark J.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1901-1911

Informa Healthcare

Access to resources Recommend Favorite

Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US

By Pike C.   Birnbaum H.   Schiller M.   Swallow E.   Burge R.   Edgell E.  

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 47-56

Springer Publishing Company

Access to resources Recommend Favorite

The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals

By  

PAIN MEDICINE, Vol. 16, Iss. 7, 2015-07 ,pp. : 1325-1332

John Wiley & Sons Inc

Access to resources Recommend Favorite

Appropriate use of inhaled corticosteroid and long-acting ßß₂-adrenergic agonist combination therapy among asthma patients in a US commercially insured population

By Ye Xin   Gutierrez Benjamin   Zarotsky Victoria   Nelson Michael   Blanchette Christopher M.  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2251-2258

Informa Healthcare

Access to resources Recommend Favorite